A16z Prognostications for 2024 https://lnkd.in/gW_Ec2cj
Brian Curran’s Post
More Relevant Posts
-
Connecting the world's applications, data and devices as a Mulesoft Account Director at Salesforce/ Double Star Ranger
The average lifespan of companies listed on the S&P 500 has dropped over 60% since 1958. We live in an era of a fast pace change, and automation and AI can help us to face all this changes in a smart way.
Survival of the Fastest: The Evolution of Business
salesforce.smh.re
To view or add a comment, sign in
-
CMO-Cigniti |M&A, Corp Dev, CVC|CSO|NUS&IIM-K Alum| Forbes, HYSEA& Nasscom Council Member|(Ex)CMO Kore.ai|(Ex)Bain&Co|B2B Marketing-Software Products& IT Services|Gen AI Foundry| Digital|AI,ML,IOT,SaaS|Angel Investor|CSR
https://lnkd.in/gxFmMPwY : Here comes the predictions for 2024.. A series of well curated ones that I will reshare from my favourite reading lists at the end of every year as to what the new year will unleash #cmoinsights #predictions2024
Big Ideas in Tech for 2024
https://a16z.com
To view or add a comment, sign in
-
Tech Predictions for 2024 #techpredictions2024 #predictions2024
CMO-Cigniti |M&A, Corp Dev, CVC|CSO|NUS&IIM-K Alum| Forbes, HYSEA& Nasscom Council Member|(Ex)CMO Kore.ai|(Ex)Bain&Co|B2B Marketing-Software Products& IT Services|Gen AI Foundry| Digital|AI,ML,IOT,SaaS|Angel Investor|CSR
https://lnkd.in/gxFmMPwY : Here comes the predictions for 2024.. A series of well curated ones that I will reshare from my favourite reading lists at the end of every year as to what the new year will unleash #cmoinsights #predictions2024
Big Ideas in Tech for 2024
https://a16z.com
To view or add a comment, sign in
-
According to a City AM article, Vishal Marria, CEO of Quantexa, shares how his experience working in his parents' shop fueled his passion for business and equipped him to lead the successful tech firm. The article discusses Quantexa's recent achievement of becoming the UK's first unicorn in 2023 and delves into Marria's mixed emotions about this milestone. Additionally, it explores Quantexa's growth plans and their anticipation of capitalizing on the next wave of expansion. To read more about this inspiring story and Quantexa's strategy, follow the link: https://okt.to/pJBUjM. #Quantexa #DecisionIntelligence
Cash and carry to billion dollar boss: Quantexa chief Vishal Marria
https://www.cityam.com
To view or add a comment, sign in
-
I help employees and employers take total control of their health insurance | Top-Rated Podcast Host | HSA Expert | Insurance Coach | Speaker | Educator
Watch and listen to Peter H. Diamandis!
“At the end of your life, how much of your capital would you spend in order to add 20 or 30 healthy years?” Peter H. Diamandis, co-founder of Fountain Life (one of our portfolio companies at Seed Healthcare), asked this on a recent feature on “Last Call” on CNBC. While discussing the longevity therapy market (anticipated to reach $44.9B in 2031 - though it's more like a multi-trillion dollar market when you consider its connection to AI), he highlighted how Fountain Life is delivering the most advanced healthcare in a system that is massively broken and more “sick” care than healthcare. We're proud to partner with Fountain Life and its founders, who are tackling challenging questions like this head on and with meaningful efforts. They recognize that seizing the opportunities available to us now can result in substantial enhancements in longevity for us and future generations. Watch the interview here: https://ow.ly/iIFf50Sa0ek
Entrepreneur Peter Diamandis discusses why longevity is next great money making opportunity
cnbc.com
To view or add a comment, sign in
-
"The connection between data availability and the ability to make decisions needs to become more evident. It is of great importance to clarify the connection between revenue growth and cost reduction." Timur Bokari, Strategy & Growth at re:cap, discusses the financial viability of the Data Team with Elizabeth Press of D3M Labs. Given the recent mass layoffs of data professionals, the accounting and financial mechanisms described by Timur Bokari should be essential knowledge for Data Leaders and data professionals. Empathy and influence without authority are both important skills. Learning how your CFO, CEO and investors look at ROI on your activities should equally be considered an essential skill for data leaders, along with the business savvy to pull it off. Read the article: https://d3mlabs.de/?p=1305 Follow D3M Labs on LinkedIn to stay updated on the discussion about the financial viability of the Data Team. Sign up for the newsletter at bit.ly/40m6vAF to stay informed about our events. We have a YouTube channel. Subscribe: https://lnkd.in/e4gRkkxk
Are Data Teams Financially Viable? Timur Bokari, Strategy & Growth at re:cap, discusses with Elizabeth Press from D3M Labs what steps business leaders and Data Leaders can take to ensure the financial viability of Data Teams. Read the article: https://d3mlabs.de/?p=1305 💰Data People: This is your opportunity to learn the mechanisms of finance and accounting that can determine your professional stability and career! 🚀One important factor remains: Data must have a clear connection to revenue growth and cost efficiency. Follow D3M Labs to continue the discussion on LinkedIn. Sign up for the newsletter at bit.ly/40m6vAF to stay informed about our events. We have a YouTube channel. Subscribe: https://lnkd.in/e8RTtx6t https://d3mlabs.de/?p=1305
Ensuring the Data Team’s Financial Viability, Beyond Cash Burn – An Interview with Timur Bokari
https://d3mlabs.de
To view or add a comment, sign in
-
How to Profit by Divesting from Companies with Anti-Israel Stances As savvy investors, we must always be alert to the implications of a company's political stance on its financial health. Take, for instance, hims & hers, whose CEO, Andrew Dudum, recently made a controversial statement about hiring pro-Palestinian protesters just days before a potentially underwhelming quarterly earnings report. This statement, coinciding with a 5% drop in share value—erasing $100 million in market equity—raises the suspicion that it might be a psychological maneuver by a CEO fearing for his job ahead of poor earnings results. Given hims & hers' history of underperformance, with shares gaining only 8.32% since its IPO compared to a 23.33% increase in the S&P 500 and similar growth in the Nasdaq, investors could have seen better returns elsewhere. Furthermore, analysts are also showing signs of concern. Recently, Jefferies downgraded hims & hers from 'Buy' to 'Hold' and reduced the price target to $15 from $17, signaling a cautious stance on the company's growth prospects. This downgrade, coupled with the anticipated poor earnings, paints a troubling picture for the future of hims & hers. Additionally, the related Supernova festival tragedy on 10/7, where victims mirror the typical hims & hers customer base, might further alienate its clientele. Customers may sympathize more with the victims than with a company perceived to be exploiting political events to distract from business failures. This scenario suggests potential for increased customer churn and a continued decline in share value, making it a critical time for shareholders to consider divesting. For those open to risk, short selling could capitalize on anticipated downturns.
To view or add a comment, sign in
-
📈 $PCRX shares surged 9.3% to close at $29.86 after the latest earnings! Revenue hit the mark, but EPS fell short, missing estimates by 17%. Curious about what's next for Pacira? Check out the latest AI forecast! 🔍 https://lnkd.in/e45NuAi6 https://lnkd.in/eMGdErqP
To view or add a comment, sign in
-
Product & Research | Motilal Oswal AMC - Index Funds & ETFs | Ex- Multi-Act Trade & Investments | Master of Finance ('21 ), NMIMS Mumbai | CFA Level III Candidate
Investors should carefully evaluate the quality of a company's earnings before making an investment decision.
While choosing promising companies is vital, an often-neglected factor is elimination. A resilient portfolio must withstand market fluctuations. This makes investing in dependable, non-risky companies crucial. When examining cases, for instance an Indian medical equipment company, this need becomes apparent. Despite impressive returns, a closer inspection revealed unreliable earnings due to questionable financial practices. This classic example underscores the importance of actively identifying and eliminating such "rogue" companies early in the investment process. Multi-Act has devised a method to assess Quality of Earnings, aiding investors in filtering out these rogues and fortifying their portfolios against unexpected downturns. To learn about the 'WHY' and 'HOW' of spotting rogue companies, read the August'23 edition of The Scanner which also features a curated Q&A with the Head of Research of Multi-Act, Nimisha Pandit, CFA. Read PDF here : https://lnkd.in/dCZM2k-d #Investors #portfolio #InvestmentManagement #RiskManagement #PortfolioOptimisation #RogueCompanies
To view or add a comment, sign in
-
**Strategic Partnerships Sparking a Brighter Future for This AI Software Stock** *Up 36% YTD, this underrated growth stock has the potential to soar higher than ever before! 🌟* In the fast-paced world of AI and software technology, one company is standing out from the crowd. With its brilliant strategic partnerships, this hidden gem is poised to revolutionize the industry and unlock unprecedented growth opportunities. **Partnering for Success: Driving Innovation in Healthcare** By forging alliances with leading healthcare providers and institutions, this AI software stock is paving the way for groundbreaking advancements in the healthcare industry. From cutting-edge diagnostics to personalized treatment plans, their innovative solutions have the potential to transform lives and improve patient outcomes. 🏥💡 **Unleashing the Power of Data: Fueling Growth and Efficiency** With access to vast amounts of data, this company harnesses the power of artificial intelligence to drive growth and enhance efficiency across various sectors. By leveraging machine learning algorithms, they provide invaluable insights that enable businesses to make informed decisions and gain a competitive edge. 💪📊 **Invest in a Future of Wellness: Why You Should Consider This Stock** While already up 36% YTD, the growth potential of this AI software stock is far from exhausted. As the demand for advanced healthcare solutions surges, their strategic partnerships position them at the forefront of innovation, making them a promising investment opportunity. Don't let the Fear of Missing Out (FOMO) hold you back! Take action now and secure your piece of the future. 💼💰 #hsa #investing #healthcare #health #family #wellness 🚀📈👨⚕️👩⚕️ *Invest wisely, build your HSA, and join the exciting journey toward a healthier, brighter tomorrow!*
1 Outstanding Growth Stock to Buy Under $30
barchart.com
To view or add a comment, sign in